NeuroOne Q4 product revenue $742K vs $69K YoY; net loss $3.1M; FDA clears OneRF Ablation System

NEUROONE MEDICAL TECHNOLOGIES Corp

Product revenue $742K (Q4) vs $69K YoY; full year $1.952M vs $171K.
Net loss $3.1M (Q4) vs $1.4M; full year $11.9M vs $10.0M.
Received FDA 510(k) clearance for OneRF Ablation System in Dec 2023; commercial launch expected H1 2024.
Cash $5.3M as of Sep 30, 2023, down from $11.1M; raised $5.2M net in public offering and $2.5M via ATM at $1.77/share.
Zimmer Biomet expanding Evo sEEG launch; device sales ramp expected quarter by quarter.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NEUROONE MEDICAL TECHNOLOGIES Corp reported fiscal fourth quarter and full fiscal year ended September 30, 2023 results: revenue Product revenue of $742,000 in Q4 2023, net income Net loss was $3.1 million for the fourth quarter of fiscal 2023.

Period: fiscal fourth quarter and full fiscal year ended September 30, 2023
Revenue: Product revenue of $742,000 in Q4 2023
Net income: Net loss was $3.1 million for the fourth quarter of fiscal 2023
Result: reported results

Exact text from the filing

On December 14, 2023, NeuroOne Medical Technologies Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter and fiscal year ended September 30, 2023.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NEUROONE MEDICAL TECHNOLOGIES Corp reported full fiscal year ended September 30, 2023 results: revenue Product revenue of $1,952,000 for FY 2023, net income Net loss was $11.9 million for the full year fiscal 2023.

Period: full fiscal year ended September 30, 2023
Revenue: Product revenue of $1,952,000 for FY 2023
Net income: Net loss was $11.9 million for the full year fiscal 2023
Result: reported results

Exact text from the filing

today announces its operating results for the fiscal fourth quarter and full fiscal year ended September 30, 2023.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

NEUROONE MEDICAL TECHNOLOGIES Corp filing history →

Source: SEC EDGAR

accession 0001213900-23-095741

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.